Log In
Thursday 21st February 2019


FT Health

What cancer taught me about the US-UK healthcare debate

The NHS has its failings — but is it better to be treated as a customer rather than a patient?

Activist targets Bristol-Myers Squibb ahead of Celgene deal

Starboard’s demand for board seats raises questions over $90bn pharma deal

CVS shares eye biggest drop since October on weak 2019 outlook

Australian vitamin producer tumbles on China slowdown

Blackmores shares fall 34% on disappointing forecasts for key market

Scientist warns against discoveries made with AI

Inaccurate findings are being made in some areas of biomedical research

Drug start-ups move out of UK’s ‘golden triangle’

Northern England’s strength in life sciences spurs businesses to develop there

FT Health: Africa’s neglected poor

Health inequalities, Fujifilm’s Kenji Sukeno, FT Health reader survey

Research shows damage depression inflicts on brain

Condition affects cognitive function and memory that scientists have linked to dementia

J&J and Novartis back cancer geneticist’s start-up

Siddhartha Mukherjee’s Vor Biopharma raises $42m for leukaemia trials

New drugs help AstraZeneca sales rebound

Pharmaceutical group confident that ‘earnings, not just sales’ will return to growth

Uncertainties around generic drugs leave cloud over Indivior’s future

Drugmaker unable to provide 2019 guidance as it pursues last-ditch attempt to block rivals

Teva stock tumbles as it warns of ‘trough’ in 2019

World’s biggest generic drugmaker cautions that sales and profits will be lower

Johnson & Johnson to buy Auris Health for $3.4bn

World’s largest healthcare group tries to speed up move into digital surgery

Keytruda shows the high price of curing cancer

Rapid medical innovation is prompting drug company mergers and making treatment costly

Merck’s Keytruda trial a boost for kidney cancer patients

The immunotherapy used with Pfizer’s Inlyta halves the risk of dying from condition

Sanofi and Regeneron cut price of Praluent by 60%

Drugmakers lower cost of anti-cholesterol drug amid slow take-up and political pressure

US drugs pricing: jagged little pill

Reducing patients’ out-of-pocket costs would lessen public anger towards Big Pharma

Smith & Nephew in talks to buy NuVasive for over $3bn

FTSE 100 medical devices maker considers acquisition of spinal surgery specialist

Cancer becomes biggest earner for London’s private hospitals

Oncology services move ahead of orthopaedics as revenue slips in the capital

Tortoise provides inspiration for diabetes pill

A new high-tech pill that could give people with diabetes an alternative to injectin…

FT Health: Cancer; mental health; EU verification

Hugh Pullen of EMVO, the march of measles, tortoise-inspired technology

Diabetes pill could inject insulin directly into stomach wall

Researchers from MIT and Novo Nordisk have tested tortoise-inspired oral insulin system

Sanofi promises growth from new drug launches

French pharma group says ‘strategic transformation has brought fruit’

GSK strategy revamp and shingles drug help lift earnings

UK drugmaker warns 2019 earnings likely to be hit by generic rival to Advair asthma drug

Eli Lilly cuts 2019 outlook after trial failure and Loxo deal

Mayden - Innovative cloud-based applications for healthcare
© Mayden Foundation 2019